Cambridge Innovation Capital (CIC) is a venture capital firm founded by the University of Cambridge in 2013, investing in deep tech and life sciences companies connected to the Cambridge ecosystem. With over £600 million in assets under management, CIC serves as a preferred investor for university spinouts and early-stage ventures across technology and healthcare sectors.
30% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (3 deals in the last 12 months vs 8 prior). Their most common stage is series-a (40% of deals). Average disclosed round size is $55.8M (across 54 rounds with reported amounts).
Portfolio
50
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
Dipesh Patel
Operating Partner
Paul Anson
Operating Partner
Robert Tansley
Partner
Humphrey Battcock
Independent Non-executive Director
Panos Kakoullis
Independent Non-executive Director
Professor Sir John Aston, Kt FRS
Non-executive Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Salience Labs | Seed | — | Sep 2026 |
 Trent AI | Seed | — | Apr 2026 |
 Immutrin | Series A | $87M | Mar 2026 |
 BeyondMath | Seed | $18.5M | Feb 2026 |
 Fluidic | Series A | $31M | Jan 2026 |
 TRIMTECH Therapeutics | Seed | $14M | Mar 2025 |
 Epitopea | Series A | $31M | Feb 2025 |
 Cambridge GaN Devices | Series C | — | Feb 2025 |
| Salience Labs | Series A | $30M | Feb 2025 |
 Forefront RF | Series A | — | Nov 2024 |
| Epitopea | Series A | $31M | Oct 2024 |
| NNuclera Ltd | Series C | $75M | Oct 2024 |
| NNuclera Ltd | Series A | $75M | Oct 2024 |
 Riverlane | Series C | $75M | Aug 2024 |
| Forefront RF | Series A | — | Jan 2024 |
 Secondmind Ltd | Bridge | $16M | Nov 2023 |
 T-Therapeutics | Series A | — | Nov 2023 |
 Complement Therapeutics | Series A | — | Apr 2023 |
| CComplement | Series A | — | Apr 2023 |
 Mosaic Therapeutics | Series A | $28M | Apr 2023 |
 Seldon | Series B | $20M | Mar 2023 |
 Seldon | Series B | $20M | Mar 2023 |
 Pragmatic | Unknown | $182M | Jan 2023 |
 Seldon | Series B | $20M | Jan 2023 |
| Riverlane | Series B | — | Jan 2023 |
Top Co-Investors
Last updated: 7 October 2026